﻿<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.google.com/schemas/sitemap/0.84" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.google.com/schemas/sitemap/0.84 http://www.google.com/schemas/sitemap/0.84/sitemap.xsd">
  <url>
    <loc>http://imitrex.legalview.com/msn/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/nupathe-inc-reports-second-quarter-2010-results/1236720/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/migraine-medication-developers-feeling-no-pain/1236719/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/leerink-swann-initiating-coverage-of-nupathe-path-with-an-outperform-s/1236718/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/san-diegos-zogenix-files-for-90m-ipo-to-expand-development-of-needle-f/1236717/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/nupathe-to-present-at-the-stifel-nicolaus-2010-healthcare-conference/1236716/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/zogenix-files-for-ipo-on-strength-of-migraine-treatment/1236715/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/curing-rebound-headaches/1236714/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/bedford-laboratories-to-begin-shipping-of-migraine-drug/1236713/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/triptan-drugs-safe-for-pregnant-women-with-migraines/1236712/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/bedford-laboratoriesa-to-begin-shipping-sumatriptan-succinate-injectio/1236711/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/emeryvilles-zogenix-plans-90-million-ipo/1236710/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/bedford-laboratories-to-begin-shipping-sumatriptan-succinate-injection/1236709/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/strides-gets-us-approval-for-migraine-drug/1198484/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/usfda-nod-for-strides-drug/1198483/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/strides-arcolab-receives-usfda-ok-for-injection/1198482/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/bse-sensex-to-tread-water-reliance-comm-eyed/1198481/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/us-fda-approves-strides-arcolabs-sumatriptan-succinate-injection/1198480/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/strides-arcolab-gets-fda-ok-for-sumatriptan-succinate-injection/1198479/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/best-of-ac-content-on-migraine-headaches-and-migraine-remedies/1198478/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/buy-tramadol-online-and-other-prescription-medicines-at-cheapusamedsco/1198477/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/womans-doc-treating-weather-related-migraines/1160247/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/spectrum-pharmaceuticals-inc-reports-operating-results-10-q/1132613/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/pozen-reports-positive-results-in-first-phase-iii-trial-of-mt-300/1132612/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/par-3q-profit-surges-on-product-sales/1132611/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/nupathe-reports-positive-phase-iii-results-for-zelrix-a-novel/1110650/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/medicated-patch-for-migraines-uses-electricity-to-push-drug-through/1110649/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/wheres-your-headache-at/1110648/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/spectrum-takes-loss-without-one-time-payment/1110647/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/caraco-pharmaceutical-laboratories-cpd-announces-settlement-of/1110646/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/par-reports-2q-profit-on-generic-toprol-sales/1110645/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/fda-approves-mylans-generic-imitrex-tablets/1110644/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
  <url>
    <loc>http://imitrex.legalview.com/msn/mylan-receives-fda-approval-for-generic-version-of-migraine-treatment/1110643/</loc>
    <lastmod>2012-02-23</lastmod>
  </url>
</urlset>
